Results 71 to 80 of about 42,476 (239)

Bariatric Surgery in the United Kingdom: A Cohort Study of Weight Loss and Clinical Outcomes in Routine Clinical Care. [PDF]

, 2015
BACKGROUND: Bariatric surgery is becoming a more widespread treatment for obesity. Comprehensive evidence of the long-term effects of contemporary surgery on a broad range of clinical outcomes in large populations treated in routine clinical practice is ...
Batterham, Rachel L, Bhaskaran, Krishnan, Douglas, Ian J, Smeeth, Liam   +3 more
core   +3 more sources

Exploring the Relationship Between Obesity, Weight Loss and Health‐Related Quality of Life: An Updated Systematic Review of Reviews

Clinical Obesity, EarlyView.
ABSTRACT The aim of this systematic literature review (SLR) of reviews was to update the evidence, established in a 2017 SLR, on the impact of obesity and weight loss by various interventions on health‐related quality of life (HRQoL). In total, eight SLRs and/or meta‐analyses published since 2017 were identified. The results consistently demonstrated a
Tone Nygaard Flølo, Hui‐Hsuan Liu, John Roger Andersen, Ronette L. Kolotkin   +3 more
wiley   +1 more source

Challenges and pitfalls of experimental bariatric procedures in rats [PDF]

, 2012
Introduction: The impact of Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) on obesity and obesity-related diseases is unquestionable. Up to now, the technical descriptions of these techniques in animals/rats have not been very comprehensive.
Becker, Kristianna, Bruckner, Thomas, Büchler , Markus W., Clemens, Gabriella, Fischer, Lars, Gehrig, Tobias, Gutt, Carsten N., Kenngott, Hannes, Müller-Stich, Beat   +8 more
core   +1 more source

Association of Weight Loss Composition Following Metabolic‐Bariatric Surgery With Incident Major Adverse Cardiovascular Events and All‐Cause Mortality

Clinical Obesity, EarlyView.
ABSTRACT Severe obesity is associated with an increased cardiovascular risk. Metabolic‐bariatric surgery (MBS) can reduce the risk of cardiovascular events and mortality, potentially depending on weight loss composition. This study assessed the association between post‐MBS weight loss composition and major adverse cardiovascular events (MACE) and all ...
Malou A. H. Nuijten, Bente M. de Roos, Jan H. M. Karregat, Eric J. Hazebroek, Valerie M. Monpellier, Ignace M. C. Janssen, Maria T. E. Hopman, Esmée A. Bakker, Thijs M. H. Eijsvogels   +8 more
wiley   +1 more source

Impact of Semaglutide on fat mass, lean mass and muscle function in patients with obesity: The SEMALEAN study

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Semaglutide, a GLP‐1 receptor agonist, has shown efficacy in promoting weight loss. However, limited data exist on its impact on lean mass, muscle function, and metabolic adaptations. The SEMALEAN study aims to evaluate these parameters in patients with obesity treated with Semaglutide (2.4 mg).
Mathieu Alissou, Thomas Demangeat, Vanessa Folope, Hélène Van Elslande, Hélène Lelandais, Julia Blanchemaison, Pierre‐Emmanuel Cailleaux, Suzan Guney, Alexandra Aupetit, Agnès Aubourg, Clément Rapp, André Petit, Morgane Godin, Luc Vignal, Sébastien Grigioni, Pierre Déchelotte, Guillaume Colange, Moïse Coëffier, Najate Achamrah   +18 more
wiley   +1 more source

Mechanisms underlying the weight loss effects of RYGB and SG: similar, yet different [PDF]

, 2018
The worldwide obesity epidemic continues unabated, adversely impacting upon global health and economies. People with severe obesity suffer the greatest adverse health consequences with reduced life expectancy.
Batterham, RL, Pucci, A
core   +1 more source

Metabolic bariatric surgery is associated with reduced adverse hepatic and extrahepatic outcomes, and lower all‐cause mortality, in patients with steatotic liver disease

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aim Metabolic bariatric surgery (MBS) improves histological endpoints in steatotic liver disease (SLD), but data on longer‐term clinical outcomes in this population are scarce. Here, we assessed the impact of MBS on hepatic and extrahepatic morbidity and mortality in individuals with SLD.
Weronika Stupalkowska, Alexander Henney, Eric G. Sheu, Uazman Alam, Daniel J. Cuthbertson   +4 more
wiley   +1 more source

Histopathological Findings in Laparoscopic Sleeve Gastrectomy Specimens from Patients with Obesity in Saudi Arabia

Gastroenterology Research and Practice, 2018
Laparoscopic sleeve gastrectomy is a bariatric surgical procedure performed in patients with morbid obesity that provides the opportunity to review histopathological changes.
Khaldoon Aljerian
doaj   +1 more source

Changes in Lean Tissue Mass, Fat Mass, Biological Parameters and Resting Energy Expenditure over 24 Months Following Sleeve Gastrectomy [PDF]

, 2023
Laurent Maı̈moun, Safa Aouinti, Marion Puech, Patrick Lefèbvre, Mélanie Delozé, Pascal de Santa Barbara, Éric Renard, Jean‐Paul Cristol, Justine Myzia, Marie‐Christine Picot, Denis Mariano‐Goulart, David Nocca   +11 more
openalex   +1 more source

Observations regarding 'quality of life' and 'comfort with food' after bariatric surgery: comparison between laparoscopic adjustable gastric banding and sleeve gastrectomy. [PDF]

, 2011
International audienceBACKGROUND: Although laparoscopic adjustable gastric banding (LAGB) and laparoscopic sleeve gastrectomy (LSG) are coexisting first-choice restrictive procedures for bariatric surgery candidates, it is possible, given their different
Ballon, Nicolas, Bourbao-Tournois, Céline, Brunault, Paul, Camus, Vincent, Couet, Charles, Huten, Noël, Jacobi, David, Léger, Julie   +7 more
core   +2 more sources